Loading…

Geistlich Pharma AG has signed an agreement to acquire Brazilian medical technology company Bionnovation Biomedical, expanding its regenerative product portfolio for dentistry in Latin America and other emerging markets.
“We are excited to be able to offer our clinicians in future an even wider range of trustworthy solutions to fulfill the medical needs of their patients.”geistlich.com
Summarized from public sources; check the original articles before acting on it.